Related Experiment Video
Updated: Aug 14, 2026
12:34
Collection, Isolation, and Flow Cytometric Analysis of Human Endocervical Samples
Published on: July 6, 2014
HPV Self-Collection Experience in US Hispanic/Latinx Women Using a Device Designed for at-Home Collection
Lisa Memmel1, LaShonda Crane2, Youri Hwang3
1Department of Obstetrics and Gynecology, Planned Parenthood Northern California, San Francisco, CA, USA.
Summary
Hispanic women face higher cervical cancer rates and screening barriers. At-home self-collection (SC) HPV testing shows promise for improving screening access and adherence in this population.
Area of Science:
- Gynecology
- Public Health
- Preventive Medicine
Background:
- Cervical cancer is preventable, yet Hispanic women in the US experience disproportionately higher incidence rates.
- Improving screening and follow-up for under-screened and high-risk populations is crucial for disease elimination.
Purpose of the Study:
- To analyze the experiences and preferences of Hispanic versus non-Hispanic participants regarding cervical cancer screening methods.
- To identify strategies for improving screening and follow-up in vulnerable populations.
Main Methods:
- A post hoc analysis of the SELF-CERV study involving 603 women (25-65 years) using a self-collection (SC) device for high-risk human papillomavirus (hrHPV) testing.
- Comparison of SC samples with clinician-collected (CC) samples, alongside usability and screening preference surveys.
Main Results:
- Hispanic women reported lower income, less insurance, and lower education levels compared to non-Hispanic women.
- Financial barriers significantly impeded screening for Hispanic women.
- Hispanic women showed significantly higher endorsement (78%) of at-home SC compared to non-Hispanic women (62%).
- Both groups indicated increased likelihood of staying up-to-date with screening using an at-home SC device.
Conclusions:
- At-home self-collection (SC) HPV testing offers a promising solution to address screening barriers faced by Hispanic women.
- Accessible, clinically validated at-home SC alternatives can significantly improve screening uptake and health outcomes in this high-risk community.